Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensor Augmented Pump (SAP) Therapy for Inpatient Cystic Fibrosis Related Diabetes (CFRD) Management

NCT03939065 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03939065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03939065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensor Augmented Pump (SAP) Therapy for Inpatient Cystic Fibrosis Related Diabetes (CFRD) Management
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Terminated
Start date
June 12, 2020
Completion date
June 30, 2022
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis in children, cystic fibrosis pulmonary exacerbation, cystic fibrosis-related diabetes